BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29250188)

  • 21. MicroRNA-31 is a potential biomarker for screening B-lymphoblastic leukemia in children.
    Zhang Y; Li X; Bai L; Li L; Li D; Ding X; Wang B; Li C
    Oncol Lett; 2019 Nov; 18(5):4930-4935. PubMed ID: 31612004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia.
    Labib HA; Elantouny NG; Ibrahim NF; Alnagar AA
    Hematology; 2017 Aug; 22(7):392-397. PubMed ID: 28253825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [THE COMPARISON OF RESULTS OF DETECTION OF MINIMAL RESIDUAL DISEASE IN PERIPHERAL BLOOD AND MARROW IN CHILDREN OF THE FIRST YEAR OF LIFE WITH ACUTE LYMPHOBLASTIC LEUCOSIS].
    Tsaur GA; Riger TO; Popov AM; Nasedkina TV; Kustanovich AM; Solodovnikov AG; Streneva OV; Shorikov EV; Tsvirenko SV; Saveliev LI; Fechina LG
    Klin Lab Diagn; 2015 Apr; 60(4):14-22. PubMed ID: 26189286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
    Hong Z; Zhang R; Qi H
    Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
    Avgeris M; Stamati L; Kontos CK; Piatopoulou D; Marmarinos A; Xagorari M; Baka M; Doganis D; Anastasiou T; Kosmidis H; Gourgiotis D; Scorilas A
    Clin Chem Lab Med; 2018 Nov; 56(12):2104-2118. PubMed ID: 30016275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia.
    Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
    Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Lin SW; Yu SL; Chen HY; Yen CT; Lin CY; Lin JF; Lin KH; Jou ST; Hu CY; Chang SK; Lu MY; Chang HH; Chang WH; Lin KS; Lin DT
    Leuk Res; 2010 Jan; 34(1):18-23. PubMed ID: 20109966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.
    Piatopoulou D; Avgeris M; Marmarinos A; Xagorari M; Baka M; Doganis D; Kossiva L; Scorilas A; Gourgiotis D
    Br J Cancer; 2017 Sep; 117(6):801-812. PubMed ID: 28787435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expression and clinical significance of miR-203 in pediatric acute leukemia].
    Wang N; Pan J; Cao L; Lu J; Xiao PF; Zhao WL; Hu SY; Chai YH
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):777-81. PubMed ID: 24103876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
    Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
    J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of bi/oligoclonality in childhood acute lymphoblastic leukemia as determined by polymerase chain reaction.
    Scrideli CA; Defavery R; Bernardes JE; Tone LG
    Sao Paulo Med J; 2001 Sep; 119(5):175-80. PubMed ID: 11723528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
    Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
    Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
    Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
    Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.
    Xiang L; Li M; Liu Y; Cen J; Chen Z; Zhen X; Xie X; Cao X; Gu W
    Ann Hematol; 2013 Aug; 92(8):1063-9. PubMed ID: 23515710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of miR-125b predicts poor response to therapy in pediatric acute lymphoblastic leukemia.
    El-Khazragy N; Elshimy AA; Hassan SS; Matbouly S; Safwat G; Zannoun M; Riad RA
    J Cell Biochem; 2019 May; 120(5):7428-7438. PubMed ID: 30390332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
    Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
    Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
    Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
    Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Real-time quantitative detection of E2A-PBX1 fusion gene in children with acute lymphoblastic leukemia and its clinical application in minimal residual disease monitoring].
    Zhang R; Liao J; Li G; Sun HQ; Shi YJ; Yang JY
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):440-3. PubMed ID: 23791058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.